Cas:12013-57-9 tellanylidenecalcium manufacturer & supplier

We serve Chemical Name:tellanylidenecalcium CAS:12013-57-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

tellanylidenecalcium

Chemical Name:tellanylidenecalcium
CAS.NO:12013-57-9
Synonyms:Calcium telluride;telluroxocalcium;Calcium telluride (CaTe);EINECS 234-589-2
Molecular Formula:CaHTe
Molecular Weight:168.68600
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:170.87700
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Calcium telluride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 234-589-2 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Calcium telluride Use and application,EINECS 234-589-2 technical grade,usp/ep/jp grade.


Related News: New Zealand on Sunday became the latest country to impose restrictions on travelers from mainland China, saying it would deny entry to visitors departing from or transiting through the mainland for two weeks starting on Monday. tellanylidenecalcium manufacturer AstraZeneca Plc said on Monday that its cancer drug met the main goal of delaying the progression of a form of lung cancer. tellanylidenecalcium supplier The purpose of APIs according to the FDA is to cause ��pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body. tellanylidenecalcium vendor The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy. tellanylidenecalcium factory The purpose of APIs according to the FDA is to cause ��pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body.